InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Benatti Luca, 董事. Director active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 6 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €147k. History available since 27 May 2021. The latest transaction was filed on 26 December 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Benatti Luca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
8,918 股Common StockSEC:0000912282-25-001468:0
50,000 股@ US$3.47100.0% 占其流量Common StockSEC:0000912282-25-001469:0
25,487 股@ US$19.00100.0% 占其流量Common StockSEC:0001104659-23-117110:0
8,111 股0Common StockSEC:0001104659-23-064846:0
7,737 股0Common StockSEC:0001104659-22-065918:0
7,029 股0Common StockSEC:0001104659-21-075215:0
6 条申报中的 6 条
About Benatti Luca
Luca Benatti is a Director at INTERCEPT PHARMACEUTICALS, INC. In this role, he participates in the governance and strategy of the company. INTERCEPT PHARMACEUTICALS, INC. is a biopharmaceutical company specializing in developing treatments for liver diseases. Luca Benatti brings his expertise in health to help guide strategic decisions.
